Skip to main content
Actuate Therapeutics, Inc. (ACTU)
Actuate Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$8.00 - $10.00
Shares Offered
5,555,556
Deal Size
$50.00M

Actuate Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
 20232022
Cash & Equivalents
2.9620.45
Cash & Cash Equivalents
2.9620.45
Cash Growth
-85.53%-
Other Current Assets
0.040.03
Total Current Assets
320.48
Total Assets
320.48
Accounts Payable
3.422.13
Other Current Liabilities
3.52.21
Total Current Liabilities
6.924.34
Other Long-Term Liabilities
1.521.31
Total Long-Term Liabilities
1.521.31
Total Liabilities
8.445.65
Retained Earnings
-105.09-80.35
Shareholders' Equity
-99.63-75.31
Net Cash / Debt
2.9620.45
Net Cash / Debt Growth
-85.53%-
Working Capital
-3.9316.14
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).